The anti-cocaine vaccine, developed by researchers at the Federal University of Minas Gerais, Brazil, aims to produce antibodies that bind to cocaine when it is taken. This would make it harder for the substance to pass through the bloodstream to the brain. The vaccine would try to inhibit the brain reactions that trigger the craving.
Latest News
22:50
German Foreign Minister warns that the Black Sea is becoming a theater of war after attacks on commercial vessels
22:36
EU signs new European protocol on the cross-border confiscation and recovery of criminal assets
22:24
The EU adopts new control rules for sprat and turbot fishing in the Black Sea
22:20
Mobility shifts medical staff between states but does not resolve the EU-wide shortage. Romania remains one of the main countries of origin
22:16
The Railway Reform Authority has designated Siemens Mobility as the winner for 23 electric locomotives, under a contract worth over 764 million lei
See more news